Digital spatial profiling of CD4+ T cells in classic Hodgkin lymphoma

被引:5
作者
Takeuchi, Mai [1 ]
Miyoshi, Hiroaki [1 ]
Semba, Yuichiro [2 ]
Yamada, Kyohei [1 ]
Nakashima, Kazutaka [1 ]
Sato, Kensaku [1 ]
Furuta, Takuya [1 ]
Moritsubo, Mayuko [1 ]
Ogura, Yusuke [1 ]
Tanaka, Ken [1 ]
Imamoto, Teppei [1 ]
Arakawa, Fumiko [1 ]
Kohno, Kei [1 ]
Ohshima, Koichi [1 ]
机构
[1] Kurume Univ, Dept Pathol, Sch Med, Kurume, Fukuoka, Japan
[2] Kyushu Univ, Dept Med & Biosyst Sci, Fac Med, Fukuoka, Fukuoka, Japan
基金
日本学术振兴会;
关键词
Classic Hodgkin lymphoma; Hodgkin-Reed-Sternberg cells; CD4(+) T cell rosettes; Digital spatial profiling; Tumor microenvironment; ANALYSIS REVEALS; EXPRESSION; MICROENVIRONMENT; BLOCKADE; DISEASE;
D O I
10.1007/s00428-023-03562-1
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Classic Hodgkin lymphoma (CHL) harbors a small number of Hodgkin-Reed-Sternberg (HRS) cells scattered among numerous lymphocytes. HRS cells are surrounded by distinct CD4(+) T cells in a rosette-like manner. These CD4(+) T cell rosettes play an important role in the tumor microenvironment (TME) of CHL. To elucidate the interaction between HRS cells and CD4(+) T cell rosettes, we completed digital spatial profiling to compare the gene expression profiles of CD4(+) T cell rosettes and other CD4(+) T cells separated from the HRS cells. Immune checkpoint molecules including OX40, programed cell death-1 (PD-1), and cytotoxic T lymphocyte associated protein 4 (CTLA-4) expression was higher in CD4(+) T cell rosettes compared to other CD4(+) T cells. Immunohistochemistry confirmed variable PD-1, CTLA-4, and OX40 expression in the CD4(+) T cell rosettes. This study introduced a new pathological approach to study the CHL TME, and provided deeper insight into CD4(+) T cells in CHL.
引用
收藏
页码:255 / 260
页数:6
相关论文
共 50 条
  • [1] Digital spatial profiling of CD4+ T cells in classic Hodgkin lymphoma
    Mai Takeuchi
    Hiroaki Miyoshi
    Yuichiro Semba
    Kyohei Yamada
    Kazutaka Nakashima
    Kensaku Sato
    Takuya Furuta
    Mayuko Moritsubo
    Yusuke Ogura
    Ken Tanaka
    Teppei Imamoto
    Fumiko Arakawa
    Kei Kohno
    Koichi Ohshima
    Virchows Archiv, 2023, 483 : 255 - 260
  • [2] Checkpoint inhibition enhances cell contacts between CD4+ T cells and Hodgkin-Reed-Sternberg cells of classic Hodgkin lymphoma
    Yadigaroglu, Kuebra
    Scharf, Sonja
    Gretser, Steffen
    Schaefer, Hendrik
    Deli, Aresu Sadeghi Shoreh
    Loth, Andreas G.
    Yegoryan, Hasmik
    Schmitz, Roland
    Donnadieu, Emmanuel
    Hansmann, Martin-Leo
    Hartmann, Sylvia
    HAEMATOLOGICA, 2024, 109 (10) : 3295 - 3304
  • [3] The Evolving Knowledge on T and NK Cells in Classic Hodgkin Lymphoma: Insights into Novel Subsets Populating the Immune Microenvironment
    Ferrarini, Isacco
    Rigo, Antonella
    Visco, Carlo
    Krampera, Mauro
    Vinante, Fabrizio
    CANCERS, 2020, 12 (12) : 1 - 20
  • [4] CD4+T cells in classical Hodgkin lymphoma express exhaustion associated transcription factors TOX and TOX2 Characterizing CD4+T cells in Hodgkin lymphoma
    Veldman, Johanna
    Placa, Jessica Rodrigues
    Chong, Lauren
    Terpstra, Miente Martijn
    Mastik, Mirjam
    van Kempen, Leon C.
    Kok, Klaas
    Aoki, Tomohiro
    Steidl, Christian
    van den Berg, Anke
    Visser, Lydia
    Diepstra, Arjan
    ONCOIMMUNOLOGY, 2022, 11 (01):
  • [5] Spatial and molecular profiling of the mononuclear phagocyte network in classic Hodgkin lymphoma
    Stewart, Benjamin J.
    Fergie, Martin
    Young, Matthew D.
    Jones, Claire
    Sachdeva, Ashwin
    Blain, Alex
    Bacon, Chris M.
    Rand, Vikki
    Ferdinand, John R.
    James, Kylie R.
    Mahbubani, Krishnaa T.
    Hook, Liz
    Jonas, Nicolaas
    Coleman, Nicholas
    Saeb-Parsy, Kourosh
    Collin, Matthew
    Clatworthy, Menna R.
    Behjati, Sam
    Carey, Christopher D.
    BLOOD, 2023, 141 (19) : 2343 - 2358
  • [6] The critical role of CD4+ T cells in PD-1 blockade against MHC-II-expressing tumors such as classic Hodgkin lymphoma
    Nagasaki, Joji
    Togashi, Yosuke
    Sugawara, Takeaki
    Itami, Makiko
    Yamauchi, Nobuhiko
    Yuda, Junichiro
    Sugano, Masato
    Ohara, Yuuki
    Minami, Yosuke
    Nakamae, Hirohisa
    Hino, Masayuki
    Takeuchi, Masahiro
    Nishikawa, Hiroyoshi
    BLOOD ADVANCES, 2020, 4 (17) : 4069 - 4082
  • [7] Multiplexed Spatial Profiling of Hodgkin Reed-Sternberg Cell Neighborhoods in Classic Hodgkin Lymphoma
    Pourmaleki, Maryam
    Jones, Caitlin J.
    Mellinghoff, Sabrina D.
    Greenstein, Brian D.
    Kumar, Priyadarshini
    Foronda, Miguel
    Navarrete, Daniel A.
    Campos, Carl
    Roshal, Mikhail
    Schultz, Nikolaus
    Shah, Sohrab P.
    Schietinger, Andrea
    Socci, Nicholas D.
    Hollmann, Travis J.
    Dogan, Ahmet
    Mellinghoff, Ingo K.
    CLINICAL CANCER RESEARCH, 2024, 30 (17) : 3881 - 3893
  • [8] Mapping the Spatial Dynamics of the CD4+T Cell Spectrum in Classical Hodgkin Lymphoma
    Menendez, Victoria
    Solorzano, Jose L.
    Garcia-Cosio, Monica
    Cereceda, Laura
    Diaz, Eva
    Estevez, Monica
    Roncador, Giovanna
    Vega, Zaira
    Montalban, Carlos
    Kulasinghe, Arutha
    Garcia, Juan F.
    MODERN PATHOLOGY, 2024, 37 (09)
  • [9] Topological importance of CD8+ T-cell enrichment in the tumor microenvironment of classic Hodgkin lymphoma
    Takahashi, Hiromichi
    Ito, Shun
    Nakanishi, Yoko
    Miura, Katsuhiro
    Nishimaki, Haruna
    Nakagawa, Masaru
    Otake, Shimon
    Hamada, Takashi
    Koike, Takashi
    Iizuka, Kazuhide
    Masuda, Shinobu
    Nakayama, Tomohiro
    Shimizu, Tetsuo
    Ishibashi, Naoya
    Kogure, Hirofumi
    Nakamura, Hideki
    ANNALS OF HEMATOLOGY, 2025, : 1047 - 1057
  • [10] Follicular Helper T-cell Lymphoma With Hodgkin/Reed-Sternberg-Like Cells Versus Classic Hodgkin Lymphoma
    Petronilho, Sara
    Poullot, Elsa
    Andre, Axel
    Robe, Cyrielle
    Nouhoum, Sako
    Fataccioli, Virginie
    Quintela, Jose Miguel
    Claudel, Alexis
    Briere, Josette
    Lechapt, Emmanuele
    Lemonnier, Francois
    Henrique, Rui
    de Leval, Laurence
    Gaulard, Philippe
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2025, 49 (03) : 273 - 283